Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Nanosonics Limited ( (AU:NAN) ) has shared an announcement.
Nanosonics Limited has provided an updated notification to the ASX regarding its ongoing on-market share buy-back program for its ordinary fully paid shares. The company reported that a total of 4,094,162 shares had been repurchased before the previous trading day, with an additional 150,000 shares bought back on the previous day as part of its daily buy-back activity.
The announcement, dated 8 April 2026, is an amendment to earlier notifications first lodged in December 2025 and most recently updated on 7 April 2026. The continued execution of the on-market buy-back signals ongoing capital management by Nanosonics, potentially supporting earnings per share and indicating confidence in the company’s valuation for existing shareholders.
The most recent analyst rating on (AU:NAN) stock is a Buy with a A$4.50 price target. To see the full list of analyst forecasts on Nanosonics Limited stock, see the AU:NAN Stock Forecast page.
More about Nanosonics Limited
Nanosonics Limited is an Australian-listed medical technology company trading under the ASX code NAN. The company is known for its infection prevention and control solutions used in healthcare settings, with its ordinary fully paid shares actively traded on the market.
Average Trading Volume: 712,562
Technical Sentiment Signal: Sell
Current Market Cap: A$1.12B
See more insights into NAN stock on TipRanks’ Stock Analysis page.